Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
1992 • 9,540 citations
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
1993 • 3,515 citations
Apoptosis. Its significance in cancer and cancer Therapy
1994 • 2,148 citations
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
1989 • 2,060 citations
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
1987 • 1,180 citations
Drugs effective in the therapy of the epilepsies
1985 • 461 citations
Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.
1985 • 414 citations
Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells.
1990 • 280 citations
Protein phosphatase type 1 in mammalian cell mitosis: chromosomal localization and involvement in mitotic exit.
1992 • 198 citations
Programmed cell death (apoptosis) and response to anti-cancer drugs
1994 • 185 citations
Cytoskeletal integrity in interphase cells requires protein phosphatase activity.
1992 • 174 citations
Relationship of p53 to the control of apoptotic cell death.
1994 • 163 citations
Multidrug Resistance and Chemosensitization: Therapeutic Implications for Cancer Chemotherapy
1990 • 116 citations
Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
1992 • 91 citations
Inhibition of mitosis by okadaic acid: possible involvement of a protein phosphatase 2A in the transition from metaphase to anaphase
1992 • 89 citations
Protein phosphatase inhibitors induce the selective breakdown of stable microtubules in fibroblasts and epithelial cells.
1993 • 88 citations
Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitro.
1994 • 84 citations
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
1987 • 75 citations
Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentiation of HL-60 leukemia cells.
1992 • 62 citations
Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
1994 • 23 citations
Multidrug‐resistant human kb carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance
1993 • 22 citations
Hydantoin drugs inhibit polymerization of pure microtubular protein.
1978 • 14 citations
Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin)
1993 • 11 citations
A comparison of potency of hydantoins in metaphase arrest and inhibition of microtubular polymerization.
1980 • 6 citations
Vinca Alkaloids and Epipodophyllotoxins
2002 • 2 citations